In today’s episode we have a few updates to discuss with everyone, and first probably the big news everyone heard about is the official approval of the BioNTech COVID vaccine just this past week. We’ll also talk through a new EUA for COVID vaccines in certain individual and approval of Welireg for adults with von Hippel-Lindau disease. Don't forget to like, share and subscribe, and ENJOY!

In today’s episode we have a few updates to talk through - the first is approval of a new Lantus biosimilar called Semglee that will be the first interchangeable insulin product. We'll also talk through approval of Nexviazyme for Pompe disease and approval of Rezurock for chronic graft vs host disease. Don't forget to like, share and subscribe, and ENJOY!

In today’s episode we only have two items for this week - that’s approval of Rylaze for certain types of ALL and LBL and the FDA issuing a new EUA for Actemra for treatment of COVID-19. Don't forget to like, share and subscribe, and ENJOY!

In today’s episodes we have two expanded indications - first is Ultomiris which is now approved for pediatric patients with paroxysmal nocturnal hemoglobinuria, and approval of Pradaxa for pediatric patients with venous thromboembolism. And we also have a product that is moving from prescription to OTC - that’s Astepro for seasonal and allergic rhinitis. Don't forget to like, share and subscribe, and ENJOY!

In today’s episode we have three new products approved by the FDA this week, including Wegovy as a treatment for chronic weight management in adults, and approval of Lybalvi a new combination product being used to treat schizophrenia and bipolar type 1. And the big news this week is the FDA approval of Aduhelm for Alzheimer's. Don't forget to like, share and subscribe, and ENJOY!

In today’s episode we have three new products approved by the FDA this week, the first is Myfembree approved for use with uterine fibroids and approval of Lumakras for a specific type of non-small cell lung cancer. We also will be discussing approval of Truseltiq for adults with cholangiocarcinoma. Don't forget to like, share and subscribe, and ENJOY!

In today’s episode we have two new products approved by the FDA, the first is Empaveli approved for paroxysmal nocuturnal hemoglobinuria, commonly referred to as PNH and also approval of Rybrevant for a specific type of non-small cell lung cancer. Don't forget to like, share and subscribe, and ENJOY!

In today’s episode we have two new products approved by the FDA this week both for types of cancer. Jemperli is approved with specific indications for endometrial cancer, and also Zynlonta is approved for specific types of large B-cell lymphoma. Don't forget to like, share and subscribe, and ENJOY!

In today’s episode the new product we’ll be discussing is Nextstellis, a new contraceptive with a new form of estrogen. We also have a product with a new indication, that’s Trodelvy which gained approval for metastatic triple-negative breast cancer and urothelial cancer. Don't forget to like, share and subscribe, and ENJOY!

In today’s episodes the new product we’ll be discussing is Qelbree for the treatment of ADHD in children and adolescents. We also have two products with new indications, Tyvaso and Sarclisa. Don't forget to like, share and subscribe, and ENJOY!